article thumbnail

Mastering healthcare data governance with data lineage

IBM Big Data Hub

Healthcare organizations need a strong data governance framework to help ensure compliance with regulations like the Health Insurance Portability and Accountability Act of 1996 (HIPAA) in the US and the General Data Protection Regulation (GDPR) in the EU. Issues with compliance and audit conduct also arise due to these scattered data sources.

article thumbnail

Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges

Hunton Privacy

Recently, Aegerion Pharmaceuticals announced that it will enter into several settlements and plead guilty to two misdemeanors in connection with alleged violations of HIPAA, drug marketing regulations and securities laws. The criminal charges stem from the company’s marketing of a cholesterol drug called Juxtapid.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to protect healthcare and life-sciences data from a cyber attack pandemic

Thales Cloud Protection & Licensing

According to analyst firm IDC , 93% of pharmaceutical companies and 72% of biotech companies already have business-critical applications in the cloud, including product lifecycle management, analytics, revenue management, and much more. The risks of non-compliance. How to protect healthcare data from a cyber attack pandemic.

article thumbnail

The Value of Data Governance and How to Quantify It

erwin

For example, one global pharmaceutical giant reduced cost by 70 percent and generated 95 percent of production code with “zero touch.” Risk Management and Regulatory Compliance. Risk management, specifically around regulatory compliance, is an important use case to demonstrate the true value of data governance.

article thumbnail

The Cloud Trust Paradox: Keeping Control of Data & Encryption Keys in the Cloud

Thales Cloud Protection & Licensing

It is as important as privacy, security and compliance. The first scenario concerns extremely sensitive, highly-regulated data, such as healthcare, financial or pharmaceutical. In this case, organizations would prefer for various risk, compliance or policy reasons to maintain this data on-premises. Compliance.

article thumbnail

New Cybersecurity Directives (NIS2 and CER) Enter into Force

Hunton Privacy

However, the concept of an “essential entity” is much broader and will also capture many organizations that have, to-date, not been subject to the NIS regime—for example, pharmaceutical companies and operators of hydrogen production, storage and transmission. Reinforced obligations. of the worldwide annual turnover.

article thumbnail

Optimizing clinical trial site performance: A focus on three AI capabilities

IBM Big Data Hub

Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.